Immunophenotyping in Metastatic Kidney Cancer Patients Receiving Ablative Therapy

Clinical trial NCT05112627 · COMPLETED

Trial details

NCT number: NCT05112627
Sponsor: Mayo Clinic
Status: COMPLETED
Study type: OBSERVATIONAL

Metastatic Renal Cell Carcinoma Stage IV Renal Cell Cancer AJCC v8

Start date: 2022-01-24
Primary completion: 2024-05-15
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.